Viewing Study NCT04862260

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-01-06 @ 10:18 AM
Study NCT ID: NCT04862260
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-22
First Post: 2021-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
Sponsor: CHU de Quebec-Universite Laval
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Ductal Adenocarcinoma View
None Pancreatic Cancer View
None Pancreas Cancer View
None Metastatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Statin View
None Atorvastatin View
None Lipitor View
None PCSK9 monoclonal antibody View
None PCSK9 inhibitor View
None PCSK9 View
None Evolocumab View
None Repatha View
None Alirocumab View
None Praluent View
None Lipid droplets and vacuoles View
None NPC1L1 transporter View
None HMG Co A reductase View
None LDL receptor View
None LRP1 receptor View
None SRB1 receptor View
None Lipids View
None Cancer View
None Cholesterol View
None Pancreas cancer View
None Pancreas/Pancreatic Cancer Metastatics View
None FOLFIRINOX View